HubXchange Oncology Companion Diagnostics EUROPE: June 29, 2022


Ted van der Lende

Wednesday, June 29 | 11:20am – 12:20pm CEST 

Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights

Presenter: Ted van der Lende, PhD
Executive Director, Europe Business Development


  • Earlier detection of disease recurrence
  • Utility in more disease indications, and at earlier stages of disease
  • Clinical trial needs for patient enrichment
  • Screening/enrollment
  • Surrogate endpoint analysis
  • Necessity for additional biomarker readouts

HubXchange Oncology Companion Diagnostics EUROPE